(in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $335.05 | $300.07 | $238.06 | $286.49 |
Inventory | ||||
Total current assets | $832.52 | $1029.69 | $872.64 | $1026.56 |
Long term investments | ||||
Property, plant & equipment | $274.65 | $278.74 | $286.15 | $293.67 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $11871.85 | $12204.14 | $12425.92 | $10947.72 |
Current liabilities | ||||
Accounts payable | $469.1 | $503.89 | $423.41 | $416.82 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $828.51 | $868.18 | $792.54 | $787.69 |
Long term debt | $8527.89 | $8204.97 | $8664.53 | $7222.74 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $11759.3 | $12072.26 | $12304.11 | $10824.39 |
Shareholders' equity | ||||
Retained earnings | $110.69 | $130.23 | $120.38 | $122.14 |
Other shareholder equity | ||||
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $0.05 | |||
Short term investments | ||||
Net receivables | $335.05 | $220.25 | $280.57 | $193.55 |
Inventory | ||||
Total current assets | $832.52 | $925.15 | $1011.66 | $0.23 |
Long term investments | ||||
Property, plant & equipment | $274.65 | $298.88 | $313.54 | $223.6 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $425.33 | |||
Total investments | ||||
Total assets | $11871.85 | $13600.63 | $22528.36 | $425.57 |
Current liabilities | ||||
Accounts payable | $469.1 | $439.72 | $1085.37 | $801.42 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $828.51 | $811.86 | $1325.55 | $5.2 |
Long term debt | $8527.89 | $9567.32 | $17995.06 | $1975.31 |
Total noncurrent liabilities | $415.37 | |||
Total debt | $8205.21 | |||
Total liabilities | $11759.3 | $13457.06 | $22385.96 | $420.57 |
Shareholders' equity | ||||
Retained earnings | $110.69 | $142.5 | $141.81 | -$5.85 |
Other shareholder equity | ||||
Total shareholder equity |
(in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $447.39 | $538.06 | $649.83 | |
Cost of revenue | ||||
Gross Profit | $389.3 | $467.86 | $575.93 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $222.56 | $220.26 | $230.19 | |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $4.77 | $0.77 | $4.04 | |
Interest expense | $163.64 | -$31.39 | $111.59 | |
Net income | ||||
Net income | $11.7 | $8.37 | $21.93 | |
Income (for common shares) |
(in millions $) | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | 31 Jan 2019 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $593.3 | |||
Cost of revenue | ||||
Gross Profit | $550 | |||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $6.63 | $0.04 | $373 | |
Operating income | -$6.63 | -$0.04 | ||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $0.08 | $0.1 | ||
Interest expense | -$85.6 | |||
Net income | ||||
Net income | -$5.81 | -$0.04 | $91.3 | |
Income (for common shares) |
(in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $1144.58 | $802.59 | $610.5 | $199.75 |
Financing activities | ||||
Dividends paid | -$27.68 | -$18.43 | -$9.17 | -$30.63 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$11888.95 | -$11935.72 | -$12192.17 | $9264.46 |
Effect of exchange rate | ||||
Change in cash and equivalents | $68.45 | $227.57 | $170.09 | -$492.75 |
(in millions $) | 31 Jan 2022 | 30 Jan 2021 | 30 Jan 2020 | 31 Jan 2019 |
---|---|---|---|---|
Net income | -$5.81 | -$0.04 | ||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$1.8 | -$0.17 | ||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $199.75 | -$425.33 | $170.7 | |
Financing activities | ||||
Dividends paid | -$30.63 | |||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $9264.46 | $427.18 | $0.17 | $728.9 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$492.75 | $0.05 | $0 | -$26.6 |
Market cap | $585.34M |
---|---|
Enterprise value | N/A |
Shares outstanding | 93.65M |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | -35.19% |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 1.00 |
Quick ratio | N/A |